Role of Polymer Architecture on the Activity of Polymer–Protein Conjugates for the Treatment of Accelerated Bone Loss Disorders

作者: Bryan S. Tucker , Jon D. Stewart , J. Ignacio Aguirre , L. Shannon Holliday , C. Adrian Figg

DOI: 10.1021/ACS.BIOMAC.5B00623

关键词:

摘要: Polymers of similar molecular weights and chemical constitution but varying in their macromolecular architectures were conjugated to osteoprotegerin (OPG) determine the effect polymer topology on protein activity vitro vivo. OPG is a that inhibits bone resorption by preventing formation mature osteoclasts from osteoclast precursor cell. Accelerated loss disorders, such as osteoporosis, rheumatoid arthritis, metastatic disease, occur result increased osteoclastogenesis, leading severe weakening bone. has shown promise treatment disorders; however, it rapidly cleared circulation through rapid liver uptake, frequent, high doses are necessary achieve therapeutic benefit. We aimed improve effectiveness creating OPG–polymer bioconjugates, employing reversible addition–fragmentation chain transfer polymerization create well-defined polymers with branching densities f...

参考文章(68)
Xudong Luan, Qingyu Lu, Yinan Jiang, Senyan Zhang, Qing Wang, Huihui Yuan, Wenming Zhao, Jiawei Wang, Xinquan Wang, Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin Journal of Immunology. ,vol. 189, pp. 245- 252 ,(2012) , 10.4049/JIMMUNOL.1103387
Ming Li, Priyadarsi De, Hongmei Li, Brent S. Sumerlin, Conjugation of RAFT-generated polymers to proteins by two consecutive thiol–ene reactions Polymer Chemistry. ,vol. 1, pp. 854- 859 ,(2010) , 10.1039/C0PY00025F
Sébastien S. Dufresne, Nicolas A. Dumont, Patrice Bouchard, Éliane Lavergne, Josef M. Penninger, Jérôme Frenette, Osteoprotegerin protects against muscular dystrophy. American Journal of Pathology. ,vol. 185, pp. 920- 926 ,(2015) , 10.1016/J.AJPATH.2015.01.006
Harm-Anton Klok, Biological-synthetic hybrid block copolymers: Combining the best from two worlds Journal of Polymer Science Part A. ,vol. 43, pp. 1- 17 ,(2005) , 10.1002/POLA.20527
Graeme Moad, Y.K. Chong, Almar Postma, Ezio Rizzardo, San H. Thang, Advances in RAFT polymerization: the synthesis of polymers with defined end-groups Polymer. ,vol. 46, pp. 8458- 8468 ,(2005) , 10.1016/J.POLYMER.2004.12.061
Yizhi Qi, Ashutosh Chilkoti, Growing polymers from peptides and proteins: a biomedical perspective Polymer Chemistry. ,vol. 5, pp. 266- 276 ,(2014) , 10.1039/C3PY01089A
N. Bucay, I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle, W. S. Simonet, osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes & Development. ,vol. 12, pp. 1260- 1268 ,(1998) , 10.1101/GAD.12.9.1260
Paul J. Kostenuik, Sean Morony, Ildiko Sarosi, Casey Capparelli, David L. Lacey, Colin R. Dunstan, Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Research. ,vol. 61, pp. 4432- 4436 ,(2001)
Claire T. Sayers, Giuseppe Mantovani, Sinead M. Ryan, Rajan K. Randev, Odin Keiper, Oksana I. Leszczyszyn, Claudia Blindauer, David J. Brayden, David M. Haddleton, Site-specific N-terminus conjugation of poly(mPEG1100) methacrylates to salmon calcitonin: synthesis and preliminary biological evaluation Soft Matter. ,vol. 5, pp. 3038- 3046 ,(2009) , 10.1039/B905335B
H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-i. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, T. Suda, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 3597- 3602 ,(1998) , 10.1073/PNAS.95.7.3597